ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 556,64
5,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vigil Neuroscience Inc (VIGL)

  7. Vigil Neuroscience Inc (VIGL) Actualités

VIGL Vigil Neuroscience Inc

3,03
0,29 (10,58%)
Après les heures de négociation
Dernière mise à jour : 22:46:47
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vigil Neuroscience Inc VIGL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,29 10,58% 3,03 22:46:47
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,72 2,67 3,05 3,03 2,74
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202422:05GLOBEVigil Presents Key Findings from ILLUMINATE & IGNITE Studies..
26/3/202412:05GLOBEVigil Neuroscience Reports Fourth Quarter and Full Year 2023..
20/3/202412:05GLOBEVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief..
13/3/202412:05GLOBEVigil Announces Upcoming Presentations at 2024 American..
12/3/202412:05GLOBEVigil Neuroscience to Present at Stifel 2024 Virtual CNS..
06/3/202422:25GLOBEVigil Announces Oral Presentation on Small Molecule TREM2..
02/3/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:05GLOBEVigil Presents Poster on Impacts of Misdiagnosis and Genetic..
14/2/202417:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:05GLOBEVigil Neuroscience to Present at Guggenheim 6th Annual..
11/1/202416:30EDGAR2Form 8-K - Current report
03/1/202422:30GLOBEVigil Neuroscience Provides 2023 Year-in-Review and..
22/11/202322:05GLOBEVigil Neuroscience to Present at Evercore ISI 6th Annual..
16/11/202322:31EDGAR2Form 8-K - Current report
16/11/202322:05GLOBEVigil Neuroscience Reports Positive Interim Data from Phase..
07/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:15EDGAR2Form 8-K - Current report
07/11/202313:05GLOBEVigil Neuroscience Reports Third Quarter 2023 Financial..
17/10/202313:05GLOBEVigil Neuroscience Announces First Participant Dosed in..
12/10/202322:06EDGAR2Form 8-K - Current report
05/10/202322:01GLOBEVigil Neuroscience to Present at Jefferies Inaugural Biotech..
26/9/202313:05GLOBEVigil Neuroscience Receives Positive Opinion from European..
13/9/202313:31EDGAR2Form 8-K - Current report
11/9/202318:00GLOBEVigil Neuroscience Presents VGL101 Complete Phase 1 Data and..
08/9/202322:10EDGAR2Form 8-K - Current report
08/9/202322:05GLOBEVigil Neuroscience Announces Update on its Small Molecule..
08/9/202313:05GLOBEVigil Neuroscience to Present at 2023 Morgan Stanley Global..
08/8/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:19EDGAR2Form 8-K - Current report
08/8/202313:05GLOBEVigil Neuroscience Reports Second Quarter 2023 Financial..
08/8/202300:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202300:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202322:05GLOBEVigil Neuroscience Appoints Christopher J. Silber, M.D. as..
01/6/202313:00GLOBEVigil Neuroscience to Present at 2023 Jefferies Global..
10/5/202313:00GLOBEVigil Neuroscience Reports First Quarter 2023 Financial..
09/5/202313:00GLOBEVigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D...
08/5/202313:08GLOBEVigil Neuroscience Launches ALSPAware to Provide Access to..

Dernières Valeurs Consultées

NASDAQ
VIGL
Vigil Neuroscience
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés